Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jamie Findlow

Showing results (1-10 of 96) with videos related to

Pageof 10
Sort By:
Human Vaccines & Immunotherapeutics|December 1, 2015
Vaccines for the prevention of meningococcal capsular group B disease: What have we recently learned?Jamie Findlow
Human Vaccines & Immunotherapeutics|June 5, 2013
Meningococcal group B vaccinesJamie Findlow
Pathogens and Disease|March 24, 2017
Does post-implementation vaccine effectiveness data support pre-implementation predictions of 4CMenB utility?Jamie Findlow, Ray Borrow
Expert Review of Vaccines|March 22, 2024
The important lessons lurking in the history of meningococcal epidemiologyRay Borrow, Jamie Findlow
Expert Review of Vaccines|March 3, 2009
Prevention of meningococcal serogroup C disease by NeisVac-CRay Borrow, Jamie Findlow
Future Microbiology|May 17, 2019
Immunogenicity and safety of meningococcal group A, C, W and Y tetanus toxoid conjugate vaccine: review of clinical and real-world evidenceJamie Findlow, Markus Knuf
Expert Opinion on Biological Therapy|May 28, 2011
Recombinant protein meningococcal serogroup B vaccine combined with outer membrane vesiclesXilian Bai, Jamie Findlow, Ray Borrow
Expert Review of Vaccines|March 2, 2019
Introduction of a second MenB vaccine into Europe - needs and opportunities for public healthJamie Findlow, Charles Nuttens, Paula Kriz
Infectious Diseases and Therapy|November 7, 2024
Global Epidemiology of Meningococcal Disease-Causing Serogroups Before and After the COVID-19 Pandemic: A Narrative ReviewSteven Shen, Jamie Findlow, Paula Peyrani
Human Vaccines & Immunotherapeutics|March 19, 2019
A review of complement sources used in serum bactericidal assays for evaluating immune responses to meningococcal ACWY conjugate vaccinesJamie Findlow, Paul Balmer, Ray Borrow
Pageof 10

Showing results (1-10 of 96) with videos related to

Sort By:
Pageof 10
Human Vaccines & Immunotherapeutics|December 1, 2015
Vaccines for the prevention of meningococcal capsular group B disease: What have we recently learned?Jamie Findlow
Human Vaccines & Immunotherapeutics|June 5, 2013
Meningococcal group B vaccinesJamie Findlow
Pathogens and Disease|March 24, 2017
Does post-implementation vaccine effectiveness data support pre-implementation predictions of 4CMenB utility?Jamie Findlow, Ray Borrow
Expert Review of Vaccines|March 22, 2024
The important lessons lurking in the history of meningococcal epidemiologyRay Borrow, Jamie Findlow
Expert Review of Vaccines|March 3, 2009
Prevention of meningococcal serogroup C disease by NeisVac-CRay Borrow, Jamie Findlow
Future Microbiology|May 17, 2019
Immunogenicity and safety of meningococcal group A, C, W and Y tetanus toxoid conjugate vaccine: review of clinical and real-world evidenceJamie Findlow, Markus Knuf
Expert Opinion on Biological Therapy|May 28, 2011
Recombinant protein meningococcal serogroup B vaccine combined with outer membrane vesiclesXilian Bai, Jamie Findlow, Ray Borrow
Expert Review of Vaccines|March 2, 2019
Introduction of a second MenB vaccine into Europe - needs and opportunities for public healthJamie Findlow, Charles Nuttens, Paula Kriz
Infectious Diseases and Therapy|November 7, 2024
Global Epidemiology of Meningococcal Disease-Causing Serogroups Before and After the COVID-19 Pandemic: A Narrative ReviewSteven Shen, Jamie Findlow, Paula Peyrani
Human Vaccines & Immunotherapeutics|March 19, 2019
A review of complement sources used in serum bactericidal assays for evaluating immune responses to meningococcal ACWY conjugate vaccinesJamie Findlow, Paul Balmer, Ray Borrow
Pageof 10